These results suggest that YAP and KRAS have similar expression patterns and prognosis, and that YAP may promote HCC progression by upregulating KRAS expression and the activity of its downstream oncogenic signaling pathway. This evidence concerns the gene KRAS and hepatocellular carcinoma.